HLA-Haploidentical Hematopoietic Cell Transplantation for Treatment of Non-Malignant Diseases Using Nonmyeloablative Conditioning and Post-Transplant Cyclophosphamide

Allogeneic hematopoietic cell transplant (HCT) is often the only curative therapy for patients with non-malignant diseases; however, many patients do not have a human leukocyte antigen (HLA)-matched donor. Historically, poor survival was seen following HLA-haploidentical HCT due to poor immune recon...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Biol Blood Marrow Transplant
Main Authors: Mallhi, Kanwaldeep K., Srikanthan, Meera A., Baker, Kelsey K., Frangoul, Haydar A., Torgerson, Troy R., Petrovic, Aleksandra, Geddis, Amy E., Carpenter, Paul A., Baker, K. Scott, Sandmaier, Brenda M., Thakar, Monica S., Skoda-Smith, Suzanne, Kiem, Hans-Peter, Storb, Rainer, Woolfrey, Ann E., Burroughs, Lauri M.
Formato: Artigo
Idioma:Inglês
Publicado em: 2020
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7306430/
https://ncbi.nlm.nih.gov/pubmed/32234377
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbmt.2020.03.018
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados